EAU Guidelines on Renal Cell Carcinoma: The 2010 Update

被引:1138
作者
Ljungberg, Borje [1 ]
Cowan, Nigel C. [2 ]
Hanbury, Damian C. [3 ]
Hora, Milan [4 ]
Kuczyk, Markus A. [5 ]
Merseburger, Axel S. [5 ]
Patard, Jean-Jacques [6 ]
Mulders, Peter F. A. [7 ]
Sinescu, Ioanel C. [8 ]
机构
[1] Umea Univ, Dept Surg & Perioperat Sci Urol & Androl, S-90185 Umea, Sweden
[2] Churchill Hosp, Dept Radiol, Oxford OX3 7LJ, England
[3] Lister Hosp, Dept Urol, Stevenage, Herts, England
[4] Charles Univ Hosp, Plzen, Czech Republic
[5] Hannover Med Sch, Dept Urol & Urol Oncol, D-3000 Hannover, Germany
[6] Univ Paris 11, Dept Urol, Bicetre Hosp, Paris, France
[7] Radboud Univ Nijmegen, Dept Urol, Med Ctr, NL-6525 ED Nijmegen, Netherlands
[8] Fundeni Clin Inst, Dept Urol & Kidney Transplantat, Bucharest, Romania
关键词
Renal cell carcinoma; Recommendations; Guidelines; Treatment; Follow-up; Diagnosis; NEPHRON-SPARING SURGERY; INTERFERON-ALPHA; RADICAL NEPHRECTOMY; DOUBLE-BLIND; CANCER; SURVIVAL; RISK; EMBOLIZATION; PAPILLARY; OUTCOMES;
D O I
10.1016/j.eururo.2010.06.032
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Context and objectives: The European Association of Urology Guideline Group for renal cell carcinoma (RCC) has prepared these guidelines to help clinicians assess the current evidence-based management of RCC and to incorporate the present recommendations into daily clinical practice. Evidence acquisition: The recommendations provided in the current updated guidelines are based on a thorough review of available RCC guidelines and review articles combined with a systematic literature search using Medline and the Cochrane Central Register of Controlled Trials. Evidence synthesis: A number of recent prospective randomised studies concerning RCC are now available with a high level of evidence, whereas earlier publications were based on retrospective analyses, including some larger multicentre validation studies, meta-analyses, and well-designed controlled studies. Conclusions: These guidelines contain information for the treatment of an individual patient according to a current standardised general approach. Updated recommendations concerning diagnosis, treatment, and follow-up can improve the clinical handling of patients with RCC. (C) 2010 European Association of Urology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:398 / 406
页数:9
相关论文
共 50 条
[1]  
[Anonymous], WHO CLASSIFICATION T
[2]  
[Anonymous], 2009, TNM Classification of Malignant Tumors
[3]   Positive Surgical Margin Appears to Have Negligible Impact on Survival of Renal Cell Carcinomas Treated by Nephron-Sparing Surgery [J].
Bensalah, Karim ;
Pantuck, Allan J. ;
Rioux-Leclercq, Nathalie ;
Thuret, Rodolphe ;
Montorsi, Francesco ;
Karakiewicz, Pierre I. ;
Mottet, Nicolas ;
Zini, Laurent ;
Bertini, Roberto ;
Salomon, Laurent ;
Villers, Arnaud ;
Soulie, Michel ;
Bellec, Laurent ;
Rischmann, Pascal ;
De La Taille, Alexandre ;
Avakian, Raffi ;
Crepel, Maxime ;
Ferriere, Jean-Marie ;
Bernhard, Jean-Christophe ;
Dujardin, Thierry ;
Pouliot, Frederic ;
Rigaud, Jerome ;
Pfister, Christian ;
Albouy, Baptiste ;
Guy, Laurent ;
Joniau, Steven ;
van Poppel, Hendrik ;
Lebret, Thierry ;
Culty, Thibault ;
Saint, Fabien ;
Zisman, Amnon ;
Raz, Orit ;
Lang, Herve ;
Spie, Romain ;
Wille, Andreas ;
Roigas, Jan ;
Aguilera, Alfredo ;
Rambeaud, Bastien ;
Martinez Pineiro, Luis ;
Nativ, Ofer ;
Farfara, Roy ;
Richard, Francois ;
Roupret, Morgan ;
Doehn, Christian ;
Bastian, Patrick J. ;
Muller, Stefan C. ;
Tostain, Jacques ;
Belldegrun, Arie S. ;
Patard, Jean-Jacques .
EUROPEAN UROLOGY, 2010, 57 (03) :466-471
[4]   Radical Nephrectomy with and without Lymph-Node Dissection: Final Results of European Organization for Research and Treatment of Cancer (EORTC) Randomized Phase 3 Trial 30881 [J].
Blom, Jan H. M. ;
van Poppel, Hein ;
Marechal, Jean M. ;
Jacqmin, Didier ;
Schroder, Fritz H. ;
de Prijck, Linda ;
Sylvester, Richard .
EUROPEAN UROLOGY, 2009, 55 (01) :28-34
[5]   Randomized trial of laparoscopic v open nephrectomy [J].
Burgess, Neil A. ;
Koo, Brendan C. ;
Calvert, Robert C. ;
Hindmarsh, Andrew ;
Donaldson, Peter J. ;
Rhodes, Michael .
JOURNAL OF ENDOUROLOGY, 2007, 21 (06) :610-613
[6]   A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study [J].
Capitanio, Umberto ;
Cloutier, Vincent ;
Zini, Laurent ;
Isbarn, Hendrik ;
Jeldres, Claudio ;
Shariat, Shahrokh F. ;
Perrotte, Paul ;
Antebi, Elie ;
Patard, Jean-Jacques ;
Montorsi, Francesco ;
Karakiewicz, Pierre I. .
BJU INTERNATIONAL, 2009, 103 (11) :1496-1500
[7]   Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy -: A multicenter European study [J].
Cindolo, L ;
Patard, JJ ;
Chiodini, P ;
Schips, L ;
Ficarra, V ;
Tostain, J ;
de La Taille, A ;
Altieri, V ;
Lobel, B ;
Zigeuner, RE ;
Artibani, W ;
Guillé, F ;
Abbou, CC ;
Salzano, L ;
Gallo, C .
CANCER, 2005, 104 (07) :1362-1371
[8]   Family History and Risk of Renal Cell Carcinoma: Results from a Case-Control Study and Systematic Meta-Analysis [J].
Clague, Jessica ;
Lin, Jie ;
Cassidy, Adrian ;
Matin, Surena ;
Tannir, Nizar M. ;
Tamboli, Pheroze ;
Wood, Christopher G. ;
Wu, Xifeng .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (03) :801-807
[9]   RETRACTED: Immunotherapy for advanced renal cell cancer - art. no. CD001425.pub2 (Retracted Article) [J].
Coppin, C ;
Porzsolt, F ;
Awa, A ;
Kumpf, J ;
Coldman, A ;
Wilt, T .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (01)
[10]   Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial [J].
Escudier, Bernard ;
Pluzanska, Anna ;
Koralewski, Piotr ;
Ravaud, Alain ;
Bracarda, Sergio ;
Szczylik, Cezary ;
Chevreau, Christine ;
Filipek, Marek ;
Melichar, Bohuslav ;
Bajetta, Emilio ;
Gorbunova, Vera ;
Bay, Jacques-Olivier ;
Bodrogi, Istvan ;
Jagiello-Gruszfeld, Agnieszka ;
Moore, Nicola .
LANCET, 2007, 370 (9605) :2103-2111